IONS - Ionis Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.08B
Enterprise Value 4.46B
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)8.39
Price/Book (mrq)8.67
Enterprise Value/Revenue 7.74
Enterprise Value/EBITDA -15.74

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 322.72%
S&P500 52-Week Change 33.90%
52 Week High 348.82
52 Week Low 332.69
50-Day Moving Average 336.88
200-Day Moving Average 340.00

Share Statistics

Avg Vol (3 month) 31.01M
Avg Vol (10 day) 31.48M
Shares Outstanding 5143.09M
Implied Shares Outstanding 6N/A
Float 8142.04M
% Held by Insiders 10.74%
% Held by Institutions 193.22%
Shares Short (May 14, 2023) 47.11M
Short Ratio (May 14, 2023) 48.02
Short % of Float (May 14, 2023) 45.88%
Short % of Shares Outstanding (May 14, 2023) 44.97%
Shares Short (prior month Apr 13, 2023) 46.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin -57.10%
Operating Margin (ttm)-80.70%

Management Effectiveness

Return on Assets (ttm)-10.75%
Return on Equity (ttm)-54.99%

Income Statement

Revenue (ttm)575.97M
Revenue Per Share (ttm)4.05
Quarterly Revenue Growth (yoy)-8.00%
Gross Profit (ttm)-257.87M
EBITDA -449.14M
Net Income Avi to Common (ttm)-328.88M
Diluted EPS (ttm)-2.36
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.35B
Total Cash Per Share (mrq)16.45
Total Debt (mrq)1.36B
Total Debt/Equity (mrq)279.79
Current Ratio (mrq)9.81
Book Value Per Share (mrq)3.40

Cash Flow Statement

Operating Cash Flow (ttm)-376.71M
Levered Free Cash Flow (ttm)-180.15M